273 related articles for article (PubMed ID: 29889907)
21. Early carcinoma of the gallbladder.
Sato T; Koyama K; Yamauchi H; Matsuno S
Gastroenterol Jpn; 1981; 16(5):459-64. PubMed ID: 7327384
[TBL] [Abstract][Full Text] [Related]
22. Surgical treatment of advanced gallbladder cancer.
Niu GC; Shen CM; Cui W; Li Q
Am J Clin Oncol; 2015 Feb; 38(1):5-10. PubMed ID: 25616200
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience.
Gold DG; Miller RC; Haddock MG; Gunderson LL; Quevedo F; Donohue JH; Bhatia S; Nagorney DM
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):150-5. PubMed ID: 19297105
[TBL] [Abstract][Full Text] [Related]
24. ACO2 and ANPEP as novel prognostic markers for gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas.
Liu Z; Yang Z; Xiong L; Li D; Zou Q; Yuan Y
Int J Clin Oncol; 2020 Jul; 25(7):1346-1355. PubMed ID: 32249333
[TBL] [Abstract][Full Text] [Related]
25. Gallbladder cancer: Defining the indications for primary radical resection and radical re-resection.
Foster JM; Hoshi H; Gibbs JF; Iyer R; Javle M; Chu Q; Kuvshinoff B
Ann Surg Oncol; 2007 Feb; 14(2):833-40. PubMed ID: 17103074
[TBL] [Abstract][Full Text] [Related]
26. Adenosquamous carcinoma of the gallbladder warrants resection only if curative resection is feasible.
Oohashi Y; Shirai Y; Wakai T; Nagakura S; Watanabe H; Hatakeyama K
Cancer; 2002 Jun; 94(11):3000-5. PubMed ID: 12115390
[TBL] [Abstract][Full Text] [Related]
27. Squamous and adenosquamous cell carcinomas of the gallbladder.
Mingoli A; Brachini G; Petroni R; Antoniozzi A; Cavaliere F; Simonelli L; Chirletti P; Modini C
J Exp Clin Cancer Res; 2005 Mar; 24(1):143-50. PubMed ID: 15943044
[TBL] [Abstract][Full Text] [Related]
28. ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
Li J; Yang ZL; Ren X; Zou Q; Yuan Y; Liang L; Chen M; Chen S
Tumour Biol; 2013 Feb; 34(1):359-68. PubMed ID: 23065574
[TBL] [Abstract][Full Text] [Related]
29. FOXP1 and FOXO3a Are Prognostic Markers in Gallbladder Squamous Cell/Adenosquamous Carcinomas and Adenocarcinomas.
Jiao J; Liu Z; Li X; Li D; Zou Q; Yuan Y
Appl Immunohistochem Mol Morphol; 2022 Nov-Dec 01; 30(10):703-712. PubMed ID: 36227108
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
[TBL] [Abstract][Full Text] [Related]
31. ACE2 and FZD1 are prognosis markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of gallbladder.
Li J; Yang ZL; Ren X; Zou Q; Yuan Y; Liang L; Chen M; Chen S
J Mol Histol; 2014 Feb; 45(1):47-57. PubMed ID: 23921915
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological features and survival outcomes of rare histologic variants of gallbladder cancer.
Akce M; Zakka K; Penley M; Jiang R; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF
J Surg Oncol; 2020 Feb; 121(2):294-302. PubMed ID: 31782161
[TBL] [Abstract][Full Text] [Related]
33. The Expression of Notch 1 and Notch 3 in Gallbladder Cancer and Their Clinicopathological Significance.
Liu L; Yang ZL; Wang C; Miao X; Liu Z; Li D; Zou Q; Li J; Liang L; Zeng G; Chen S
Pathol Oncol Res; 2016 Jul; 22(3):483-92. PubMed ID: 26634853
[TBL] [Abstract][Full Text] [Related]
34. Decreased expression of hsa‑miR‑372 predicts poor prognosis in patients with gallbladder cancer by affecting chloride intracellular channel 1.
Zhou N; Cheng W; Peng C; Liu Y; Jiang B
Mol Med Rep; 2017 Nov; 16(5):7848-7854. PubMed ID: 28944858
[TBL] [Abstract][Full Text] [Related]
35. Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a population-based analysis.
Zhou J; Wu SG; Sun JY; Li FY; Lin HX; Chen QH; He ZY
J Cancer Res Clin Oncol; 2017 Jan; 143(1):115-122. PubMed ID: 27646608
[TBL] [Abstract][Full Text] [Related]
36. Adenosquamous carcinoma of the gallbladder.
Kondo M; Dono K; Sakon M; Shimizu J; Nagano H; Nakamori S; Umeshita K; Wakasa K; Monden M
Hepatogastroenterology; 2002; 49(47):1230-4. PubMed ID: 12239911
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological features of gallbladder papillary adenocarcinoma.
Wan X; Zhang H; Chen C; Yang X; Wang A; Zhu C; Fu L; Miao R; He L; Yang H; Zhao H; Sang X
Medicine (Baltimore); 2014 Dec; 93(27):e131. PubMed ID: 25501049
[TBL] [Abstract][Full Text] [Related]
38. Primary carcinoma of the gallbladder.
Beltz WR; Condon RE
Ann Surg; 1974 Aug; 180(2):180-4. PubMed ID: 4842979
[TBL] [Abstract][Full Text] [Related]
39. EphB1 and Ephrin-B, new potential biomarkers for squamous cell/adenosquamous carcinomas and adenocarcinomas of the gallbladder.
Yuan Y; Yang ZL; Miao XY; Liu ZR; Li DQ; Zou Q; Li JH; Liang LF; Zeng GX; Chen SL
Asian Pac J Cancer Prev; 2014; 15(3):1441-6. PubMed ID: 24606480
[TBL] [Abstract][Full Text] [Related]
40. High rate of positive lymph nodes in T1a gallbladder cancer does not translate to decreased survival: a population-based, propensity score adjusted analysis.
Köhn N; Maubach J; Warschkow R; Tsai C; Nussbaum DP; Candinas D; Gloor B; Schmied BM; Blazer DG; Worni M
HPB (Oxford); 2018 Nov; 20(11):1073-1081. PubMed ID: 29891423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
